Individualized Drugs’ Selection by Evaluation of Drug Properties, Pharmacogenomics and Clinical Parameters: Performance of a Bioinformatic Tool Compared to a Clinically Established Counselling Process

PURPOSE: Inefficacy and safety concerns are main medications’ problems, especially in the case of poly-therapies, when drug–drug interactions may alter the expected drug disposition. Ongoing efforts are aimed to establish drug selection processes aimed to preemptive evaluation of a plethora of facto...

Descripción completa

Detalles Bibliográficos
Autores principales: Borro, Marina, Gentile, Giovanna, Preissner, Sally H, Pomes, Leda Marina, Gohlke, Björn-Oliver, Del Casale, Antonio, Eckert, Andreas, Marchetti, Paolo, Preissner, Saskia, Preissner, Robert, Simmaco, Maurizio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8352633/
https://www.ncbi.nlm.nih.gov/pubmed/34385834
http://dx.doi.org/10.2147/PGPM.S316556

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8352633/
https://www.ncbi.nlm.nih.gov/pubmed/34385834
http://dx.doi.org/10.2147/PGPM.S316556

Ejemplares similares